1st Quarter - Report

HEALTHFUTURES, LLC for LIFE TECHNOLOGIES

Period 1st Quarter 2010 Filed Apr 15, 2010 Signed by Joyce Briscoe, VP-Administration

Official filing
Firm
HEALTHFUTURES, LLC
Client
LIFE TECHNOLOGIES
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

No Bill#, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —
KATHRYN SCHUBERT —

Contacted: Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Natl Science Foundation (NSF); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 805 (111th)

Health Issues HCR

No Bill#, Genomics and Personalized Medicine Act, Personalized medicine HR 3590, Patient Protection and Affordable Care Act, Pandemic influenza HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —
KATHRYN SCHUBERT —

Contacted: SENATE; Natl Science Foundation (NSF); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3590 (111th), H.R. 805 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.